A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients

Both genetic variants and messenger RNA (mRNA) expression of DNA repair and tumor suppressor genes have been investigated as molecular markers for therapy outcome. However, the phenotypic impact of genetic variants often remained unclear, thus the rationale of their use in risk prediction may be lim...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Carcinogenesis
Egile Nagusiak: Woelfelschneider, Andreas, Popanda, Odilia, Lilla, Carmen, Linseisen, Jakob, Mayer, Claudia, Celebi, Oktay, Debus, Jürgen, Bartsch, Helmut, Chang-Claude, Jenny, Schmezer, Peter
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2008
Gaiak:
Molecular Epidemiology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7110227/
https://ncbi.nlm.nih.gov/pubmed/18332046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgn067
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak